Hims & Hers Health Inc
NYSE:HIMS

Watchlist Manager
Hims & Hers Health Inc Logo
Hims & Hers Health Inc
NYSE:HIMS
Watchlist
Price: 30.56 USD 8.56% Market Closed
Market Cap: $7B

EV/EBIT

60.4
Current
12%
More Expensive
vs 3-y average of 53.8

Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.

EV/EBIT
60.4
=
Enterprise Value
$3.7B
/
EBIT
$121.7m

Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.

EV/EBIT
60.4
=
Enterprise Value
$3.7B
/
EBIT
$121.7m

Valuation Scenarios

Hims & Hers Health Inc is trading above its 3-year average

If EV/EBIT returns to its 3-Year Average (53.8), the stock would be worth $27.23 (11% downside from current price).

Statistics
Positive Scenarios
0/3
Maximum Downside
-68%
Maximum Upside
No Upside Scenarios
Average Downside
49%
Scenario EV/EBIT Value Implied Price Upside/Downside
Current Multiple 60.4 $30.56
0%
3-Year Average 53.8 $27.23
-11%
Industry Average 19.2 $9.74
-68%
Country Average 19.6 $9.93
-68%

Forward EV/EBIT
Today’s price vs future ebit

Today's Enterprise Value EBIT Forward EV/EBIT
$3.7B
/
Jan 2026
$121.7m
=
60.4
Current
$3.7B
/
Dec 2026
$160.6m
=
23.1
Forward
$3.7B
/
Dec 2027
$203.4m
=
18.3
Forward
$3.7B
/
Dec 2028
$283.5m
=
13.1
Forward
$3.7B
/
Dec 2029
$371.4m
=
10
Forward
$3.7B
/
Dec 2030
$554m
=
6.7
Forward
$3.7B
/
Dec 2031
$575.6m
=
6.5
Forward
$3.7B
/
Dec 2032
$667m
=
5.6
Forward
$3.7B
/
Dec 2033
$806.5m
=
4.6
Forward

Forward EV/EBIT shows whether today’s EV/EBIT still looks high or low once future ebit are taken into account.

Peer Comparison

All Multiples
EV/EBIT
P/E
All Countries
Close
Market Cap EV/EBIT P/E
US
Hims & Hers Health Inc
NYSE:HIMS
6.9B USD 60.4 54.1
US
CVS Health Corp
NYSE:CVS
99.1B USD 14.2 56
US
Cigna Group
XMUN:CGN
69.7B EUR 10 13.5
US
Cigna Corp
NYSE:CI
72.6B USD 0 12.2
DE
Fresenius Medical Care AG
XMUN:FME
23.1B EUR 16.8 23.6
DE
Fresenius SE & Co KGaA
XETRA:FRE
22.7B EUR 13.7 17.9
US
Quest Diagnostics Inc
NYSE:DGX
21.8B USD 15.8 21.4
US
Laboratory Corporation of America Holdings
NYSE:LH
21.7B USD 17.2 24.7
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
10.8B EUR 9.9 11.1
US
Guardant Health Inc
NASDAQ:GH
11.6B USD -27.7 -27.9
US
DaVita Inc
NYSE:DVA
10.4B USD 9.8 13.9

Market Distribution

Higher than 90% of companies in the United States of America
Percentile
90th
Based on 8 638 companies
90th percentile
60.4
Low
0 — 13.6
Typical Range
13.6 — 27.8
High
27.8 —
Distribution Statistics
the United States of America
Min 0
30th Percentile 13.6
Median 19.6
70th Percentile 27.8
Max 1 826 183.2

Hims & Hers Health Inc
Glance View

Once upon a time in the bustling landscape of telehealth services, Hims & Hers Health Inc. emerged as a pioneering force, reshaping the narrative around personal wellness and healthcare accessibility. Founded with a direct-to-consumer approach, the company cleverly positioned itself at the intersection of convenience and necessity. Operating primarily through an online platform, Hims & Hers offers a range of health-related products and services targeting conditions often stigmatized or considered sensitive, such as hair loss, erectile dysfunction, skincare, mental health, and more. The company’s business model hinges on its ability to bypass traditional healthcare barriers, providing easy access to licensed healthcare professionals and personalized treatment plans through a seamless internet-based interface. Their revenue model is multifaceted, but at its core are product sales and subscription services. Customers begin their journey by completing a brief online consultation, which, in many states, can involve a healthcare professional reviewing their information without an in-person visit. Once approved, the company's network of telehealth providers prescribes medications, which are conveniently delivered to customers’ doorsteps. Whether purchasing single products or opting for monthly subscriptions, users are drawn to the discretion and accessibility of the service. Hims & Hers markets its offerings directly through savvy digital campaigns, leveraging the power of modern e-commerce to reach younger demographics who appreciate privacy and efficiency in managing their health. Thus, the company stands as a compelling example of how technology can democratize healthcare, wrapped seamlessly within the bounds of consumer-friendly digital infrastructure.

HIMS Intrinsic Value
23.17 USD
Overvaluation 24%
Intrinsic Value
Price $30.56
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett